ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2020 Congress

July 12-14, 2020. Virtual Congress.

View by Title View by Number View Themes
Jump to:  View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z
  • Abstract Number: PB1745

    NAADP/SERCA3-Dependent Ca2+ Stores Pathway Specifically Controls Early Autocrine ADP Secretion Potentiating Platelet Activation

    M. Feng1, Z. Elaïb1, D. Borgel1, C. Denis1, F. Adam1, M. Bryckaert1, J.-P. Rosa1, R. Bobe2

  • Abstract Number: PB1756

    NADPH Oxidase 1 and Protein Disulphide Isomerase Synergize to Modulate Platelet Function

    R. Gaspar1, G. Little1, T. Sage1, G. Pula2, J. Gibbins1

  • Abstract Number: PB2490

    National Survey about Management of Venous Thromboembolism (VTE) Associated with Pregnancy / Puerperium or Oral Contraceptives in Uruguay

    V. Mérola, V. Zubiaurre, S. Grille, A.C. Pizzarossa, L. Nicassio, M. Lorenzo, M.N. Spangenberg, G. Dos Santos, L. Díaz, C. Guillermo, R. Martínez

  • Abstract Number: PB0739

    Nattokinase – Inhibition of Melanin Synthesis (Whitening Effect)

    H. Sumi1, Y. Yanagisawa2, S. Naito1, C. Yatagai1

  • Abstract Number: PB0173

    Natural Anticoagulant from Peony

    M. Lyapina1, E. Maystrenko2, M. Kalugina1

  • Abstract Number: PB0170

    Natural Compounds as Anticoagulant Drug: A New Avenue for Improving Thrombosis Outcome

    S. Sharma1, I. Garg1, T. Bhakuni2, M.A. Jairajpuri2, B. Kumar1, M.Z. Asharf1,3

  • Abstract Number: PB0508

    Negative Efect of Pre Pre-Analytical Error Sources on the APTT Test

    C. Delianu, L.L. Hurjui, M. Moscalu, C.C. Tarniceriu, I. Hurjui, O.-V. Badulescu, L. Foia

  • Abstract Number: PB1949

    Neointimal Hyperplasia Regression using Lipid- Based Encapsulated Methotrexate Nanoparticles- Mediated Catheter- Based Low- Level Blue Laser Photodynamic Therapy

    H. Mehrad1, A. Foletti2

  • Abstract Number: OC 11.5

    NETosis in Pregnancy: Role of Different Histones Subtypes

    M. Fortier1, L. Vincent1, E. Mousty2, C. Demattei3, M. Herzog4, G. Rommelaere4, E. Mercier1,5,6, E. Nouvellon1, V. Letouzey2,7, S. Bouvier1,5,6, J.-C. Gris1,5,6

  • Abstract Number: PB0256

    Neutralization of Osocimab-Induced Anticoagulation with Prothrombin Complex Concentrate, Activated Prothrombin Complex Concentrate and Recombinant Activated FVII in vitro

    A. Buchmueller1, A. Wilmen1, V. Laux2

  • Abstract Number: PB1922

    Neutrophil Activity in Patients with Antiphospholipid Syndrome-Related Thrombosis

    B.M. Mazetto1, B.W. Hounkpe2, A.P.R. Santos1, B. Jacintho1, G.L.T.V. Mesquita1, C.O. Vaz1, J. Annichino-Bizzacchi2, É. De Paula2, F.L.A. Orsi2,3

  • Abstract Number: PB0392

    Neutrophil Extracellular Trap in Patients with Peritoneal Carcinomatosis of Several Origins

    S. Mirshahi1,2, I. Aldybiat1, G. Contant2, M. Pocard1, J. Soria1, M. Mirshahi1

  • Abstract Number: PB2018

    Neutrophil Extracellular Traps (Nets) Increase the Pro-Tumoral Properties of the Human Breast Cancer Cell Line, MCF7

    K. Cardoso1, V. Almeida1, K. Bagri2, M.-I. Rossi2, C. Mermelstein2, S. König2, R. Monteiro1

  • Abstract Number: OC 05.3

    Neutrophil Extracellular Traps and Inflammasomes Form an Inflammatory Circuit Promoting Venous Thrombosis

    J. Campos1, T. Ponomaryov1, A. De Prendegast1, A. Brill1,2

  • Abstract Number: PB/CO08

    Neutrophil Extracellular Traps Infiltrate Lung Vascular, Interstitial and Airway Compartments in Severe Covid-19

    C. Oury1, C. Radermecker2, N. Detrembleur3, J. Guiot4, M. Henket4, C. D'Emal1, C. Vanwinge5, D. Cataldo5, P. Delvenne3, T. Marichal2

  • Abstract Number: PB2005

    Neutrophilic Extracellular Traps (NETs) Are a Subset of Smudge Cells Identifiable by Peripheral Smear Autoanalyzers

    M. Reyes-Gil1, D. Yin2, K. Fedorov2, M. Barouqa1, K. Ikemura1, M. Kushnir2, H. Billett2

  • Abstract Number: PB1950

    Neutrophils and Neutrophil Extracellular Traps (NETs) Can Promote Clotting and Impact Clot Structure in a Distinctive Manner

    Y. Shi1, S.R. Baker2, J.S. Gauer1, H. Philippou1, S.D. Connell3, R.A.S. Ariens1

  • Abstract Number: PB0452

    Neutrophils Extracellular Traps (NETs) Contribute to Thrombin Generation (TG) Potential in Patients with Essential Thrombocythemia (ET)

    S. Gamba1, C.J. Tartari1, M. Herre2, M. Marchetti1, L. Russo1, C. Verzeroli1, C. Giaccherini1, A. Vignoli1, A.K. Olsson2, A. Falanga1,3

  • Abstract Number: PB1447

    New Clues to GNE Gene Role in the Pathogenesis of Inherited Thrombocytopenias

    I. Persico1, R. Bottega2, F. Faletra2, T. Giangregorio2, P. D'Adamo1,2, A.M. Bianco2, A. Pastore3, P. Grotto4, M. Gabelli5, A. Biffi5, A. Burlina5, A. Marzollo5, A. Savoia1,2

  • Abstract Number: PB1145

    New Factor VIII Function-Mimetic Bispecific Antibodies Engineered from Emicizumab for Further Improving the Treatment of Hemophilia A

    Y. Teranishi1, T. Soeda2, H. Koga3, K. Yamaguchi3, K. Kato3, A. Muto2, K. Esaki3, M. Okuda1, M. Sato3, N. Shibahara3, K. Yamaguchi3, T. Wakabayashi3, H. Shiraiwa2, H. Konishi3, H. Kitamura3, T. Kitazawa3, T. Igawa1,3

  • Abstract Number: PB0532

    New Formula of “Ratio of Inhibited Thrombin Generation” Based on Modified Diluted Prothrombin Time Reagent Predicts Bleeding Risk of Patients with Low Coagulation Activity in Direct Oral Anticoagulants Therapy

    O. Kumano1, S. Suzuki2, M. Yamazaki3, Y. An4, M. Yasaka5, M. Ieko6, the Japanese Study Group for the Effect Confirmation of Direct Oral Anticoagulants

  • Abstract Number: PB0336

    New Hyperactive Factor IX Variants Identified with a Novel Computational Analysis

    T. Daniel1, J. Chau1, V. Arruda1,2, B. Samelson-Jones1,2

  • Abstract Number: PB0211

    New Peptide Inhibitors of Serine Proteases of the Blood Coagulation System

    L. Mukhametova1,2, E. Ivanova1, R. Aisina1, T. Voyushina3, N. Sokolenko3

  • Abstract Number: PB0021

    New Rat Model of Ferric Chloride-induced Acute Coronary Artery Thrombosis for Pharmaceutical Treatment of Myocardial Infarction

    C.-E. Laurent, É. Dupré, E. Demeule, D. Salvail

  • Abstract Number: PB0679

    New Ready-to-Use Liquid Multiplatform Global Screening Assays with Extended Stabilities to Facilitate Laboratory Practice

    M. Peyrafitte, C. Dunois, S. Molton, V. Villedieu, J. Amiral

  • Abstract Number: PB0816

    Next Generation Sequencing Antibody Repertoire Analysis of Inhibitory Immune Response in Hemophilia A

    W.D. Lees1, E. Wozniak2, P. Batty2,3, C.A. Mein2, A.J. Shepherd1, D.P. Hart2,3

  • Abstract Number: PB2175

    No Agreement among Risk Prediction Scores for Venous Thromboembolism in Cancer Patients: A Prospective Cohort Study

    M. Evelyn Alves de Almeida, G. da Silva Souza Gois, T. Ramires Rodrigues Alencar, S. Aparecida de Lima Montalvão, B. Moraes Martinelli, I. Macedo Toni, J. Barreto Carvalheira, M. Etchebehere, N. Adami Andreollo, J. Cesar Teixeira, J. Maria Annichino-Bizzacchi, ADVENTH Cancer Investigators

  • Abstract Number: PB2119

    No Impact of Previous Venous Thromboembolism on the Survival of Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Refractory Lymphoma

    J. Rupa-Matysek, M. Joks, M. Matuszak, A. Łojko-Dankowska, L. Gil

  • Abstract Number: PB1071

    No Peak of New-onset Inhibitors in the Aging Hemophilia Population: An International, Retrospective, Observational, Cohort Study of New Inhibitors in People with Hemophilia Aged 40 Years and Older (the NIAP Study)

    J. Astermark1, M. Carvalho2, P. De Moerloose3, R. D'Oiron4, G. Dolan5, P. Fontana3, C. Hermans6, P.A. Holme7, O. Katsarou8, G. Kenet9, R. Klamroth10, A. Lubetsky9, M.E. Mancuso11, N. Marquardt12, R. Núñez13, I. Pabinger-Fasching14, R. Schutgens15, C. Tait16, ADVANCE Working Group

  • Abstract Number: PB0936

    No Relapse in Patients with Previous Inhibitors Switched to rFVIIIFc in Ongoing Observational Phase 4 Studies

    J. Oldenburg1, C. Heller2, H. Malmström3, B. Winding3, S. Lethagen3,4

  • Abstract Number: PB0855

    Non-Human Glycans Regulate FVIII Inhibitor Formation in Mice

    C. Arthur1, P. Zerra1,2, J. Wang1, S. Shin1, C. Doering1,2, P. Lollar1,2, S. Meeks1,2, S. Stowell1

  • Abstract Number: PB0130

    Non-Invasive Optical in vivo Imaging Reveals Tumor-Derived Prothrombin with a Functional Role in Hemostasis and Tumor Progression

    L.K. Schott1,2,3, L. Pruschinski1,2,3, S. Khokar1,2,3, L. Eder1,2,3, K. Muhammad1,2,3, S. Tokalov1,2,3, J. Satrapa1,2,3, M. Klein4, K. Lackner3, S. Danckwardt1,2,3

  • Abstract Number: PB2047

    Non-Persistence to Direct Oral Anticoagulants and Risk of Thromboembolic Stroke among Patients with Non-Valvular Atrial Fibrillation: A Dutch Nationwide Cohort Study

    M.M.A. Toorop1, Q. Chen1, V. Tichelaar2, S.C. Cannegieter1, W.M. Lijfering1

  • Abstract Number: PB2111

    Non-Randomized Patient Outcomes. ADAM-VTE Registry Analysis

    E. Wysokinska1, D. Houghton2, D. Hodge1, A. Ashrani3, W. Wysokinski2, C. Loprinzi4, R. McBane2

  • Abstract Number: PB1736

    Non-redundant Roles of Platelet Glycoprotein VI and IIb/IIIa via Syk Kinase in Fibrin-dependent Thrombus Shielding under Flow

    G. Perrella1,2, J. Huang1,3, I. Provenzale1, F. Swieringa1, F.C.J.I. Heubel-Moenen4, R.W. Farndale5, M. Roest6, M. Thomas2, R.A.S. Ariëns1,7, M. Jandrot-Perrus8, S.P. Watson1,2,9, P.E.J. van der Meijden1, J.W.M. Heemskerk1

  • Abstract Number: PB1005

    Non-Sever Hemophilia Is Not Benign? – Insights from the PROBE Study

    C. Chai-Adisaksopha1, R. Curtis2, N. Frick3, M. Nichol4, D. Noone5, F. Germini6, B. O'Mahony5, D. Page7, J. Stonebraker8, M. Skinner6,9, A. Iorio10,11, PROBE

  • Abstract Number: PB2046

    Non-Valvular Atrial Fibrillation Patients Anticoagulated with Rivaroxaban Compared with Warfarin Exhibit Attenuated Plasma Platelet Activation Markers and Pro-Inflammatory Extracellular Vesicle Proteomic Signatures

    L. Weiss1, P.B. Szklanna1, W. Uhrig1, K. Ewins2, J. Keaney3,4, T. Prendiville2, S. Kelliher2, C. Hanley2, Á. Lennon2, E. Dillion5, A. Blanco6, S. Murphy3,7,8, F. Ní Áinle1,3,9, P.B. Maguire1,10

  • Abstract Number: PB0200

    Nontoxic Polyphosphate Inhibitor that Reduces Thrombosis without Increased Bleeding

    S.A. Smith1, C.C. La2,3, M.D.G. Jaraquemada-Peláez3, S. Abbina2,4, L.A. Creagh5, R. Adili6, M. Holinstat6, C.A. Haynes5, J.H. Morrissey1, J.N. Kizhakkedathu2,3,4

  • Abstract Number: PB1979

    Novel Anti-Inflammatory Network: The Phosphatase Domain of Soluble Epoxide Hydrolase Mediates the regulation of β2 Adrenergic Receptor-IL-6 Signaling and Vascular Endothelial Activation

    E. Suzuki, M. Nakano, H. Kinoshita, K. Hasumi

  • Abstract Number: PB0136

    Novel Mouse Model for Studying Hemostatic Function of Human Platelets

    D.S. Paul1,2, W. Bergmeier1,2

  • Abstract Number: PB0149

    Novel Oral Anticoagulants Do Not Expand Haematoma Volume in a Intracerebral Hemorrhage Model in Rats

    J. Ferreira1, R. Fonseca2, P. Coelho3, P. Rosado2, P. Mourao1

  • Abstract Number: PB1694

    Novel Role for Intracellular Lipases in Platelets

    M. Goeritzer1, S. Schlager1, N. Vujic1, S. Rainer1, D. Kolb1, M. Mussbacher2, A. Schlagenhauf1, H. Haidl1, C.T. Madreiter-Sokolowski1, W.F. Graier1, D. Kratky1

  • Abstract Number: PB1854

    Novel Urokinase-derived Peptides Inhibiting the Pro-tumoral Activity of Cancer-associated Fibroblasts

    M.P. Stoppelli1, S. Belli1, P. Franco1, A. De Vincenzo1, F. Iommelli1, S. Del Vecchio2, L. Telesca1, P. Grieco3, A. Carotenuto3

Jump to:  View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley